Defending Design Defect Claims? High Court Has Your Back
On June 24, 2013, the U.S. Supreme Court ruled 5-4 that under PLIVA Inc. v. Mensing (2011), state-law design defect claims against generic drug manufacturers that turn on the adequacy of...To view the full article, register now.
Already a subscriber? Click here to view full article